GHK-Cu and GSH-Cu Both Permeate Stratum Corneum Lipid Membrane Models In Vitro
Background
Dermatological dysfunctions linked to copper deficiency in the skin represent an active area of therapeutic and cosmetic research. Copper is a trace element critical to multiple skin-repair processes, yet transepidermal delivery remains difficult because the stratum corneum forms a dense lipid barrier that restricts ionic and molecular transport. Over recent years, transepidermal copper delivery has attracted growing interest, prompting incorporation of copper compounds into active cosmetic formulations. Despite this commercial momentum, the transport behavior of copper complexed with tripeptides — specifically glycyl-histidyl-lysine (GHK) and gamma-glutamyl-cysteinyl-glycine (GSH) — through the stratum corneum has received very little mechanistic attention, creating a knowledge gap that limits rational formulation design.
Study Design
An in vitro permeation study was conducted using GHK-Cu and GSH-Cu as test compounds. A Franz diffusion cell apparatus served as the experimental platform, with a liposome membrane composed of liquid crystalline systems as the barrier model. These liquid crystalline lipid systems were selected because their physicochemical properties closely resemble the intercellular cement of the stratum corneum, making them a validated standard model of the skin's horny lipid layer. The primary endpoint was the ability of each copper-peptide complex to permeate through the membrane and the influence of the peptide ligands on the dynamics of copper ion diffusion.
Results
Both GHK-Cu and GSH-Cu demonstrated the ability to permeate through liposome membranes modeling the horny lipid layer of the stratum corneum under the in vitro experimental conditions employed. The presence of the peptide ligand in each complex was shown to influence the dynamics of copper ion diffusion through the model membrane, indicating that complexation with tripeptides meaningfully alters transport behavior relative to copper ions alone. The study confirmed that the peptide component is not merely a carrier scaffold but an active modulator of the diffusion process across lipid barrier systems.
The copper complexes with both tripeptides — GHK-Cu and GSH-Cu — permeated the stratum corneum lipid model membrane, and the peptide ligands directly influenced the dynamics of copper ion transport.
No specific quantitative permeation rates, flux values, or comparative fold-differences between GHK-Cu and GSH-Cu were reported in the available abstract text.
Key Findings
- GHK-Cu permeated a liposome membrane model of the stratum corneum in a Franz diffusion cell.
- GSH-Cu also permeated the same lipid membrane model system.
- Peptide complexation with copper altered the dynamics of copper ion diffusion through the model barrier.
- Liquid crystalline liposome systems with physicochemical properties resembling intercellular stratum corneum cement were validated as the barrier model.
Why It Matters
Confirming that GHK-Cu permeates a validated stratum corneum lipid model provides mechanistic support for the inclusion of copper-peptide complexes in topical cosmetic and pharmaceutical products, moving beyond empirical formulation toward evidence-based design. For formulators and clinicians, the finding that peptide complexation alters copper diffusion dynamics means that the choice of carrier peptide — GHK versus GSH — may be a meaningful variable worth optimizing rather than treating as interchangeable. Practitioners using topical GHK-Cu preparations for skin repair or anti-aging protocols now have in vitro mechanistic backing that the active complex does reach beyond the surface barrier. Full clinical translation still requires ex vivo human skin studies and in vivo pharmacokinetic data to determine actual tissue levels and therapeutic dosing windows.
TitrateLab articles covering GHK-Cu
Written by TitrateLab, separately from the study summarized above.
